Whole Genome Sequencing clinical trials

Explore recruiting whole genome sequencing clinical trials.

Recruiting whole genome sequencing studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Whole Genome Sequencing trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

ProTarget - A Danish Nationwide Clinical Trial on Targeted Anti‐Cancer Treatment based on Genomic Profiling

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Improved breast cancer therapy (I-BCT-1) in the neoadjuvant and metastatic setting: A phase 2 clinical trial protocol studying biological rationale for the optimal selection of treatment regimens.

Norway

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Intravenous Fosfomycin in hospitalized patients with complicated urinary tract infections due to Third-generation cephalosporinresistant Enterobacterales

Italy

Therapeutic use (Phase IV) EU CTIS Study details

Comparison between esketamine nasal spray versus aripiprazole, both in combination with an antidepressant, in the refractory major depression disorder (RMDD) in elderly patients (CESAR)

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Intensified Monitoring of PhArmacology of Cabozantinib as a tool for Toxicity management in patients with renal cell carcinoma

Italy

Therapeutic use (Phase IV) EU CTIS Study details

SAFETY AND EFFICACY OF A 10-DAY COURSE OF REMDESIVIR TO PREVENT SEVERE COVID-19 IN ASYMPTOMATIC OR PAUCISYMPTOMATIC SARS-COV-2-POSITIVE KIDNEY TRANSPLANT RECIPIENTS: A SINGLE-ARM PROOF-OF-CONCEPT INTERVENTIONAL TRIAL

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

Whole Genome Sequencing trials by city

Whole Genome Sequencing in Toronto Whole Genome Sequencing in Vancouver Whole Genome Sequencing in Montreal Whole Genome Sequencing in Calgary Whole Genome Sequencing in Edmonton Whole Genome Sequencing in Ottawa Whole Genome Sequencing in Winnipeg Whole Genome Sequencing in Quebec City Whole Genome Sequencing in Hamilton Whole Genome Sequencing in Kitchener Whole Genome Sequencing in London Whole Genome Sequencing in Halifax Whole Genome Sequencing in New York Whole Genome Sequencing in Los Angeles Whole Genome Sequencing in Chicago Whole Genome Sequencing in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease